Targeting Malaria, Mutagenic Power of 5-chlorocytosine, and Rethinking Ribosomes  by unknown
Chemistry & Biology
SelectTargeting Malaria, Mutagenic Power of
5-chlorocytosine, and Rethinking Ribosomes
Each month, Chemistry & Biology Select highlights a selection of research reports from the recent
literature. These highlights are a snapshot of interesting research done across the field of chemical
biology. Our August 2015 selection includes a new look at host/parasite interplay that governs
heme biosynthesis in parasite-infected red blood cells during the blood stage of malaria, an insight
into 5-chlorocytosine as a mutagenic lesion that causes C-to-T change and might be a big contrib-
utor to inflammation-caused cancer formation, and the construction of a new ribosome that is fully
compatible with formation of truly orthogonal genetic systems.Sigala et al. report a set of interesting
observations related to the heme biosynthesis
during the blood stage of malarial infection,
which culminates in a proof-of-concept
demonstration showing that the effectiveness
of an existing antimalarial drug, artemisinin, can
be extended when combined with a heme
precursor and chemiluminescence-based
photodynamic therapy agent.
The National Institutes of Health.Heme Biosynthesis Caught between the Host
and the Parasite
Malaria is an invisible disease for those living in developed countries and yet an
everyday reality for people living in Africa and some regions of Southeast Asia.
According to the US Centers for Disease Control and Prevention, almost
200million cases ofmalaria were reported in 2013 The disease claimed approx-
imately half a million lives; tragically, mostly those of children.
We know a great deal about malaria. It is mosquito-borne illness caused by
parasites of the genus Plasmodium. We also know a considerable amount
about the life cycle of the parasites. Once in the human host, they spend
some time in the liver, where they reproduce asexually until the liver cells
burst. The parasites then enter red blood cells and go through multiple rounds
of asexual multiplication, bursting erythrocytes and entering new ones.
During this stage, known as the blood stage, the symptoms begin. While in
the erythrocytes, parasites consume huge amounts of hemoglobin that red
blood cells carry, generating copious heme, which is intriguing given that
Plasmodium genome sequencing revealed the presence of the intact heme
biosynthetic pathway. Additionally, more recent work demonstrated that
knocking out a critical gene in this pathway had no effect on the growth of
the parasites.
Sigala et al. now provide robust evidence that the relationship between the
malarial parasites and erythrocytes with respect to heme biosynthesis is far
more complex than originally thought. Upon infection, parasites are able to
change permeability of the erythrocytes’ membranes to allow larger quantities
of a heme precursor molecule, 5-aminolevulinic acid (ALA), to enter the red
blood cell. This exogenous ALA stimulates heme production, and it does so
not by stimulating the porphyrin biosynthesis apparatus of the parasite, which the authors show is dispensable, but by
stimulating the quiescent porphyrin biosynthesis pathway of the host cells, which can link up with the final parasite
enzyme to make heme. Sigala et al. go from these fascinating observations to the proof of concept demonstration that
combining ALA with luminol, a chemiluminescence-based photodynamic therapy (CL-PDT) agent, and a chemiluminescence
enchancer, either 4-iodophenol or the antimalarial drug, artemisinin, leads to effective blockade of parasite growth, including
the strains that have developed resistance to artemisinin alone. Eradicating malaria will take more than a single therapeutic
approach, but the more we know about the basic biology of the Plasmodium parasites, the closer we are to finding their
Achilles’ heel(s).
Sigala et al. (2015). eLife. Published Online July 14, 2015. http://dx.doi.org/10.7554/eLife.09143Bleaching the DNA: From Inflammation to Cancer
Inflammation is a normal response to pathogens and damaged cells that our bodies launch to stem the tide of their harmful
effects. One type of weapon that inflammation has at its disposal is a reactive chemical species that causes damage to the
proteins and DNA of the invaders. Hypochlorous acid (HOCl), also found in bleach as hypochlorite, is one such chemical spe-
cies that reacts with both proteins, leading to formation of chlorinated tyrosines, and nucleic acids, in which the main product
of chlorination is 5-chlorocytosine (5ClC). Inflammation is tightly regulated to minimize damage to the surrounding healthyChemistry & Biology 22, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 977
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arthritis and cancer. Whether any of these side effects are due to HOCl-induced 5ClC formation is not clear.
Fedeles et al. now show that 5ClC is an intrinsically mutagenic DNA lesion and that it causes significant levels of C-to-T
transition. Based on the results of assays the authors performed, the rate of change is on par with the notorious 8oxoG.
Fedeles et al. also show that all DNA polymerases handled 5ClC lesion in a similar way, decoding it as C most of the time,
but also as T 3%-9% of the time. To cast more light on what happens at the molecular level, Fedeles et al. solved three crystal
structures: one of DNA polymerase b (pol b) bound to DNA and two that along with the DNA also included either the incoming
correct dNTP, dGTP, or themutagenic dATP. The structures showed that 5Cl substituent is accommodated in themajor grove
of the DNA and that 5ClC assumes an anti-conformation that allows it to form appropriate Watson–Crick hydrogen bonding
interactions with the incoming nucleotide, be it dGTP or dATP. Based on their results, Fedeles et al. propose that 5ClC is an
important component of inflammation driven genetic modifications that lead to tumors, acting through both a previously re-
ported epigenetic mechanism and the intrinsic mutagenic effect now described.
Fedeles et al. (2015). Proc. Natl. Acad. Sci. USA. http://dx.doi.org/10.1073/pnas.1507709112Ribosome can be viewed as a busy assembly
line, such as the assembly line for the F4D-1
Skyray at the Douglas plant in El Segundo,
California (USA), except that instead of the
planes, it produces proteins. The work by Orelle
et al. opens an interesting opportunity in the
engineering of ribosomes that accept
alternative building blocks, so that one day we
can produce proteins and protein-like
molecules with features not found in nature.
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Protein synthesis by ribosomes with tethered
subunits.
978 Chemistry & Biology 22, August 20, 2015 ª2Rethinking Ribosomes
Ribosomes are complex cellular machineries that translate genetic code into a
specific protein sequence. This means that most paths to developing a capa-
bility of creating systems with alternative genetic codes and unnatural protein
sequences must lead through the ribosomes. Given the complexity of the ribo-
somes and the process of protein biosynthesis, it is not surprising that
achieving complete genetic orthogonality is a difficult task. Some of the diffi-
culty is due to the fact that ribosome is made of two subunits that come
together and fall apart at different stages of translation, which means that it
is impossible to ensure orthogonality when using engineered ribosomal sub-
units in the in vivo setting.
Orelle et al. describe an elegant solution to this problem: using ribosomes
with tethered subunits. Despite its conceptually elegant nature, this was a
difficult engineering task with a high probability of failure. But by using what
is known about the structure of the ribosome and especially how two ribo-
somal RNAs (rRNAs), 23S from large and 16S rRNA from small ribosomal sub-
units, come together, Orelle et al. first created a series of circularly permu-
tated 23S rRNAs, identified the most promising one, and then linked it to
16S via a series of linkers to generate a series of single, hybrid 16S-23S
rRNA molecules. One of these molecules, Ribo-T, works. This is a result of
fundamental interest because it provides the first experimental evidence
that the two ribosomal subunits do not need to disengage fully in order for
translation to operate. As a proof-of-concept, the authors showed that
orthogonal Ribo-T can be evolved to have an improved ability to translate pro-
tein sequences that are difficult for wild-type ribosomes to handle. This workpaves the way to the use of Ribo-T and its variants to produce protein biosynthesis and push it into interesting new
directions.
Orelle et al. (2015) Nature. http://dx.doi.org/10.1038/nature14862
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